According to a report by Intel Market Research, the global MRI Guided Focused Ultrasound Device Market was valued at USD 1.05 billion in 2025 and is estimated to reach USD 1.14 billion in 2026. The market is projected to reach USD 2.14 billion by 2034, representing a CAGR of 8.2% during 2026–2034. MRI-guided focused ultrasound combines focused acoustic energy with magnetic resonance imaging for treatment planning, targeting and thermal monitoring, enabling incisionless ablation across neurological, oncological and other therapeutic applications.
Explore the full report: MRI Guided Focused Ultrasound Device Market Report
Why Is Demand Increasing?
- Expanding treatment adoption: More than 74,800 patients received focused-ultrasound treatments during 2025, while nearly 2,000 commercial focused-ultrasound devices were installed worldwide by the end of the year.
- Neurological indications are expanding: FDA approval of staged bilateral pallidothalamic tractotomy for advanced Parkinson’s disease expanded the clinical pathway for MR-guided focused ultrasound.
- Growing research ecosystem: The focused-ultrasound field reached 391 clinical research sites worldwide, with 196 indications under investigation by the end of 2025, creating opportunities beyond established thermal ablation.
Non-Invasive Therapy Industry Watch
The MRI-guided focused ultrasound industry is moving from a specialized technology niche toward a broader installed-base treatment model. Neurology remains a major catalyst, while prostate treatment is developing into a second important commercial franchise. Real-time MR thermometry, improved treatment planning, broader MRI compatibility and expanding reimbursement are helping hospitals increase the utilization potential of installed systems. Research is also extending into blood-brain barrier opening, drug delivery, immunomodulation and neuromodulation. However, adoption remains closely tied to MRI infrastructure, treatment-site economics, patient selection and reimbursement. This makes clinical evidence, scanner compatibility and hospital partnerships increasingly important competitive factors.
Segmentation Highlights
- By Type: Prostate Cancer, Uterine Fibrosis, Breast Cancer, Liver Cancer, Bone Metastases and Others.
- Leading Type: Prostate Cancer is the most widely adopted report-defined Type.
- By Application: Hospitals, Specialty Clinics, Ambulatory Surgical Centers and Others.
- Leading Application: Hospitals dominate because of their MRI infrastructure, multidisciplinary teams and ability to manage complex neurological and oncological cases.
Regional Outlook
North America is the largest regional market and represented more than 40% of global revenue in the report’s 2024 benchmark. Early FDA approvals, advanced MRI infrastructure and reimbursement development support the region’s leadership. Asia-Pacific is the fastest-growing major region, supported by Japan’s mature installed base, China’s expanding hospital infrastructure and domestic manufacturing activity, and growing therapeutic-ultrasound activity in South Korea.
Download the free sample: Request the MRI Guided Focused Ultrasound Device Report Sample
Why This Market Matters
MRI-guided focused ultrasound represents a convergence of imaging, precision energy delivery and minimally invasive therapy. Unlike conventional surgery, the technology can deliver focused acoustic energy to targeted tissue without a surgical incision while MRI provides anatomical guidance and thermal monitoring.
The commercial opportunity is increasingly connected to utilization of installed systems rather than equipment sales alone. Additional indications, reimbursement coverage, MRI compatibility and clinical evidence can increase treatment volume at existing sites. At the same time, high capital costs and dependence on specialized MRI infrastructure remain important barriers for smaller healthcare providers.
Competitive Landscape
- Insightec Ltd. — Leads transcranial MRgFUS commercialization through Exablate Neuro, neurological indications, MRI compatibility and clinical development.
- Profound Medical Corp. — Competes through TULSA-PRO and its MRI-guided prostate tissue-ablation platform.
- Alpinion Medical Systems — Participates in the broader therapeutic-ultrasound ecosystem with imaging and focused-ultrasound capabilities.
- Theraclion SA — Competes within non-invasive therapeutic ultrasound and ablation technologies.
- EDAP TMS S.A. — Participates in therapeutic ultrasound and non-invasive tissue-treatment technologies.
Explore the complete market analysis: MRI Guided Focused Ultrasound Device Market Report
Frequently Asked Questions
What is the MRI Guided Focused Ultrasound Device Market forecast?
The market is estimated at USD 1.14 billion in 2026 and is projected to reach USD 2.14 billion by 2034 at a CAGR of 8.2%.
Which region leads the market?
North America is the largest regional market, while Asia-Pacific is the fastest-growing major region.
What is driving market growth?
Major growth factors include expanding neurological and oncology indications, increasing treatment sites, real-time MR thermometry, broader MRI compatibility and improving reimbursement.
What Does the Full Report Cover?
The complete study provides a detailed assessment of the MRI Guided Focused Ultrasound Device Market through 2034, covering disease-specific Types including prostate cancer, uterine fibrosis, breast cancer, liver cancer, bone metastases and other applications. It analyzes Hospitals, Specialty Clinics, Ambulatory Surgical Centers and other care settings, together with regional and country-level market conditions. The report also examines MR thermometry, thermal ablation, transcranial treatment, MRI compatibility, treatment planning, regulatory developments, reimbursement and clinical adoption. Competitive analysis evaluates company positioning, installed bases, indication exposure, technology development and hospital partnerships, helping stakeholders assess market-entry opportunities and future treatment-platform utilization.
Final CTA
View the complete report: MRI Guided Focused Ultrasound Device Market Report
Download the free sample: MRI Guided Focused Ultrasound Device Report
About Intel Market Research
Intel Market Research is a provider of strategic market intelligence covering healthcare, pharmaceuticals, biotechnology and related industries. Its research provides market sizing, forecasting, segmentation, regional analysis and competitive intelligence for business decision-making.
Contact
Website: www.intelmarketresearch.com
Asia-Pacific: +91 9169164321
